ADEQUATE LOCOREGIONAL TREATMENT FOR EARLY BREAST-CANCER MAY PREVENT SECONDARY DISSEMINATION

被引:171
作者
ARRIAGADA, R
RUTQVIST, LE
MATTSSON, A
KRAMAR, A
ROTSTEIN, S
机构
[1] KAROLINSKA HOSP, RADIUMHEMMET, CTR ONCOL, S-10401 STOCKHOLM, SWEDEN
[2] DANDERYD HOSP, DEPT ONCOL, S-18288 DANDERYD, SWEDEN
关键词
D O I
10.1200/JCO.1995.13.12.2869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyze different events that determine event-free survival (EFS) in a randomized trial on adjuvant radiotherapy in early breast cancer patients with more than 15 years of follow-up evaluation. Patients and Methods: The trial included 960 patients with a unilateral, operable breast cancer, Surgery consisted of a modified radical mastectomy. The trial compared three arms, as follows: preoperative radiotherapy, postoperative radiotherapy, and no adjuvant treatment, Events were analyzed by a competing-risk approach. A proportional hazards multiple regression model was used to analyze the effects of radiotherapy on the risk of distant metastasis. Similar analyses were performed separately for node-negative [N(-)] and node-positive [N(+)] patients in the two groups that did not include preoperative radiotherapy. Results: Radiotherapy produced a fivefold decrease of the risk of local recurrence (P < .0001), In N(+) patients, postoperative radiotherapy decreased the risk of distant dissemination (relative risk, 0.63). When local recurrence was introduced in the model as a time-dependent covariate, this factor wets predictive of distant dissemination (P < .0001) and nullified the effect of postoperative radiotherapy. This finding suggests that the decrease of distant metastases was related to the prevention of local recurrence. A similar effect was found in models that used overall survival as an end point. Conclusion: This study shows that postmastectomy radiotherapy in N(+) breast cancer patients may decrease the distant metastasis rate by preventing local recurrences and thus avoiding secondary dissemination. (C) 1995 by American Society of Clinical Oncology.
引用
收藏
页码:2869 / 2878
页数:10
相关论文
共 39 条
[1]   LONG-TERM EFFECT OF INTERNAL MAMMARY CHAIN TREATMENT - RESULTS OF A MULTIVARIATE-ANALYSIS OF 1195 PATIENTS WITH OPERABLE BREAST-CANCER AND POSITIVE AXILLARY NODES [J].
ARRIAGADA, R ;
LE, MG ;
MOURIESSE, H ;
FONTAINE, F ;
DEWAR, J ;
ROCHARD, F ;
SPIELMANN, M ;
LACOUR, J ;
TUBIANA, M ;
SARRAZIN, D .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (03) :213-222
[2]   RADIOTHERAPY ALONE IN BREAST-CANCER .1. ANALYSIS OF TUMOR PARAMETERS, TUMOR DOSE AND LOCAL-CONTROL - THE EXPERIENCE OF THE GUSTAVE-ROUSSY INSTITUTE AND THE PRINCESS MARGARET HOSPITAL [J].
ARRIAGADA, R ;
MOURIESSE, H ;
SARRAZIN, D ;
CLARK, RM ;
DEBOER, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10) :1751-1757
[3]   ADJUVANT CHEMOTHERAPY IN EARLY BREAST-CANCER AND INCIDENCE OF NEW PRIMARY MALIGNANCIES [J].
ARRIAGADA, R ;
RUTQVIST, LE .
LANCET, 1991, 338 (8766) :535-538
[4]   POST-MASTECTOMY MEGAVOLTAGE RADIOTHERAPY - THE OSLO AND STOCKHOLM TRIALS [J].
AUQUIER, A ;
RUTQVIST, LE ;
HOST, H ;
ROTSTEIN, S ;
ARRIAGADA, R .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :433-437
[5]   ADJUVANT SYSTEMIC THERAPY FOR BREAST-CANCER IN THE ELDERLY - COMPETING CAUSES OF MORTALITY [J].
CASTIGLIONE, M ;
GELBER, RD ;
GOLDHIRSCH, A .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :519-526
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
CUZICK J, 1987, CANCER TREAT REP, V71, P15
[8]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453
[9]  
DOMBERNOWSKY P, 1994, ANN ONCOL S8, V5, P2
[10]  
Early Breast Cancer Trialists' Collaborative Group, 1990, TREATMENT EARLY BREA, V1